Skip to main content
Signal8

Menon Sandeep

SEC insider (Form 3/4/5 filer). CIK 0002123967. Chief R&D Officer at BIOCRYST PHARMACEUTICALS INC (BCRX). 1 reported Form 4/5 transaction since Sep 2024; latest on Apr 6, 2026. Located in DURHAM, NC.

Companies Menon Sandeep has filed insider reports for

  • BIOCRYST PHARMACEUTICALS INC (BCRX): Officer, Chief R&D Officer
Menon Sandeep profile photo

Menon Sandeep

CIK: 0002123967

Transaction Breakdown

Open Market Buys (P)0 (0.0%)

High conviction signal

Open Market Sales (S)0 (0.0%)

Position reduction

Option Exercises (M)0 (0.0%)

Derivative conversions

Awards (A)1 (100.0%)

Compensation grants

Other (G, F, J, C, D, …)0 (0.0%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (1)

BIOCRYST PHARMACEUTICALS INC logo
BCRX

BIOCRYST PHARMACEUTICALS INC

Officer

Discretionary Trading P&L

Holdings

Transaction History (1 total)

  • BIOCRYST PHARMACEUTICALS INC logo
    BCRX

    BIOCRYST PHARMACEUTICALS INC

    Apr 6, 2026
    Award
    Direct
    205.2K shares-

1-1 of 1